Marketresearchnews

Tuesday, 2 March 2021

Alpha-1 Antitrypsin Deficiency Treatment Market Trends And Drivers Analysis 2020 To 2023

Global Alpha-1 Antitrypsin Deficiency Treatment Market is expected to cross USD 2,914.7 Million by 2025 at a CAGR of 10.50%.

Growing product pipeline for alpha-1 antitrypsin drugs and rising prevalence of alpha-1 antitrypsin deficiency are set to drive the market growth for alpha-1 antitrypsin deficiency treatment. Approximately 100,000 people in the US are known to suffer from alpha-1 antitrypsin deficiency.

Rising awareness regarding the alpha-1 antitrypsin deficiency is expected to drive the growth of the global alpha-1 antitrypsin deficiency treatment market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8319

The market is dominated by numerous established players. The key players are involved in product launches, strategic collaborations, and awareness programs to strengthen their market positions. For instance, in November 2018, Grifols S. A. launched the AlfaCare therapy program for training and counseling of patients diagnosed with alpha-1 antitrypsin deficiency.

Market Influencer

The prevalence of alpha-1 antitrypsin deficiency (AATD) is increasing, which is directly responsible for the growth of the global alpha-1 antitrypsin deficiency treatment market. Strategic initiatives, mergers & acquisitions, partnerships, agreements, product launches, government approvals, and expansion of manufacturing facilities by major competitors are expected to further boost market growth during the forecast period.

Segmentation

By Drugs:

Alpha-1 Proteinase Inhibitor: The segment is expected to hold the largest market share as it is the only treatment for AATD, which protects the patient from more lung damage.
Bronchodilators: These are used for the treatment of respiratory disorders associated with AATD.
Steroids: These are used specifically for the treatment of chronic obstructive pulmonary disease, which affects the patient along with AATD.
Others: Other treatment options include antibiotics for infections and jaundice associated with AATD and oxygen therapy.

By Route of Administration:

Oral: The segment is expected to hold the largest market share.
Intravenous: The segment is expected to grow at the fastest CAGR.
Inhalation: This route of administration is used specifically for the administration of corticosteroids for treating breathing disorders.
Others: Subcutaneous and intramuscular routes of administration.

By Distribution Channel:

Hospital Pharmacy: The rise in the number of hospitals is likely to be responsible for the largest market size.
Retail Pharmacy: These fulfill the requirement of drugs that are needed for treatment at home.
Online Stores: The fastest-growing segment owing to increase in number of online pharmacies.

By Region

Americas: The region holds the largest share of the market. The market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

Europe: The European alpha-1 antitrypsin deficiency treatment market has been classified as Western Europe and Eastern Europe. The Western European market has further been categorized as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

Asia-Pacific: The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Asia-Pacific alpha-1 antitrypsin deficiency treatment market is projected to be the fastest-growing during the forecast period.

Middle East & Africa: The market in the Middle East & Africa has been divided into the Middle East and Africa.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/alpha-1-antitrypsin-deficiency-treatment-market-8319
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Forensic Swab Market 2020–By Identifying The Key Market Segments And Key Players Holding Market Share

The Global Forensic Swab Market is expected to register 5.8% CAGR and is anticipated to reach USD 49.09 Million by 2023. Forensic swabs are extensively used by forensic scientists and crime scene investigators for collecting a wide range of evidence-samples such as blood, saliva, and DNA. These samples are analyzed in the laboratory for desired results. Gathering biological samples for successive DNA analysis is one of the major applications for forensic swabs. Rising criminal activities, increasing adoption of DNA forensics, growing forensic biotechnology sector, and favorable government support are some of the major factors driving the market growth during the forecast period. However, factors such as the high price of DNA free forensic swabs and irregular supply of new products in the market are projected to restrain the market growth. However, the growing rate of chronic and infectious diseases, increased research and development investment (R&D), and technological advancements are expected to boost the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6929

Market Dynamics

The past few years, there has been an increase in criminal activities and reported crimes has increased. According to crime statistics published by the Federal Bureau of Investigation, approximately 17,250 murders were estimated to be reported within the US in 2016. The government support for forensics-related activities is one of the major factors driving the global forensic swab market. The judicial framework of various countries has realized the importance of forensics. Currently, forensics is being utilized as toxicology forensics, DNA forensics, and others for investigating criminal offenses. According to a report on forensic science published by the National Criminal Justice Reference Service, the National Institute of Justice received a funding of USD 125 million through the Department of Justice Appropriations Act in 2017 for boosting DNA and other related forensic programs and activities and sexual assault forensic exams.

Segmentation

The global forensic swab market has been segmented into type, type of swab shaft, and end user.

Based on type, the global market has been segmented into foam, flocked, and cotton.

Based on type of swab shaft, the global market has been segmented into wood-stick shaft, polystyrene shaft.

Based on end user, the global market has been divided into forensic science laboratories and hospitals.

Key Players

The prominent players in the global forensic swab market are Becton, Dickinson and Company Thermo Fisher Scientific Inc., Merck KGaA, Copan Italia S.p.A., MWE, SARSTEDT AG & Co. KG, Luna, Puritan Medical Products, Sirchie, and MEDTECH Forensics.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/forensic-swab-market-6929

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Non-Invasive Monitoring Device Market 2020 Market Challenge, Driver, Trends & Forecast To 2023

The Global Non-Invasive Monitoring Device Market is expected to register a CAGR of 6.80% and is anticipated to reach USD 21,586.2 Million by 2023. Monitoring the patient condition is one of the significant parts of any treatment process for any disease condition. Monitoring devices are playing a vital role in providing the best possible care to the patients. There are three types of monitoring devices; invasive, minimally invasive, and non-invasive monitoring devices. Non-invasive devices are in high demand from the healthcare providers as well as patients due to their advantages over invasive monitoring. Non-invasive monitors are very much different from invasive monitors in terms of their working principle. Non-invasive monitors do not require rupturing of skin and penetration of any device into the body of the patient. Non-invasive monitors have sensors attached which play an essential role in generating readings of the body vitals.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1506

The increasing prevalence of cardiovascular diseases, increasing adoption of non-invasive technology, increasing prevalence of neurovascular diseases, increasing geriatric population, and favorable reimbursement policies are the major drivers propelling market growth. However, the erroneous readings and stringent regulatory norms constrain the growth of the market.

Market Dynamics

According to a report published in 2015 by the Center for Disease Control and Prevention (CDC), every year, more than 630,000 Americans die from heart diseases. Moreover, according to a report published by the CDC, in 2017, nearly 30.3 million people have diabetes only in the US. That means, one person out of every ten people has diabetes. Increasing prevalence of cardiovascular diseases has created a unique demand for advanced non-invasive monitoring devices. Additionally, increasing risks and patients suffering from diabetes & obesity, developing technology, and growing demand for monitoring devices will fuel the growth of the market during the forecast period.

Segmentation

The global non-invasive monitoring device market has been segmented into type, modality, application, and end user. By type, the market has been segmented into cardiac monitoring devices (electrocardiography and cardiac output monitors), brain monitoring devices, blood pressure monitoring devices, anesthesia monitoring devices, and blood glucose monitoring devices. Based on modality, the market has been segregated into table-top devices and wearable devices. By application, the market has been divided into cardiology, neurology, and oncology. On the basis of end-user, the market has been classified as hospital & clinics, diagnostic centers, and research & academic institutes. The hospitals and clinics segment accounted for a market value of USD 5457.4 million in 2016.

Key Players

The prominent players in the global non-invasive monitoring device market are General Electric Company (US), Medtronic PLC (Ireland), KONINKLIJKE PHILIPS NV (Netherlands), Abbott (US), Omron Corporation (Japan), Vaso Corporation (US), Integrity Applications (Israel), CAS Medical Systems, Inc. (US), A&D Medical Inc. (Japan), Tensys Medical Inc (US), OrSense Ltd (Israel), CNSystems Medizintechnik AG (Austria), NIMedical (Israel) and Advanced Brain Monitoring, Inc (US).

Some of the key strategies followed by the players operating in the global non-invasive monitoring device market were innovation, product development, acquisition, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/non-invasive-monitoring-device-market-1506

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Monday, 1 March 2021

Healthcare IoT Security Market Expected To Boost During 2020 To 2025

The Global Healthcare IoT Security Market is expected to register 39.44% CAGR and is anticipated to reach USD 130,629.55 Million by 2025. Individuals today are using various kinds of networked devices to learn more about their health and daily regime. Home monitoring of aging population related to medical emergencies and medical adherence has become possible due to the increasing use of mHealth applications and smart pills.

However, the rewards of IoT also comes with the aspect of concern regarding the security and the privacy of the patient healthcare data. Mobile and wearable devices, pacemakers, insulin pumps, and other medical systems in the IoT create more access points prone to hackers. The security solutions and services play a critical role for the healthcare organizations to perform vulnerability management and secure the protected health information passing from IoT devices to the healthcare organizations.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/946

Market Dynamics

The market for healthcare IoT security is expected to register double-digit growth during the forecast period. The major factors influencing the growth of the market include increased data privacy concerns among consumers, increased government concerns over healthcare IoT security, increased usage of smart devices for health management and increased proliferation of cybercrimes in healthcare.

With the emergence of IoT in healthcare, consumers can now track their health in real time and simultaneously share healthcare information with their caregivers and healthcare organizations. However, the ease and usage of these devices are also raising security concerns among consumers. As the use of IoT increases, data privacy concerns are bound to increase and hence, will act as a key driver for the healthcare IoT security market, globally.

Segmentation

The global healthcare IoT security market has been segmented into components, security type, application.

Based on component, the global market is divided into solution and service.

Based on solution type, the global market has been segmented into analytics, encryption, data loss protection, identity and access management, unified threat management, and others.

Based on service type, the global market has been segmented into consulting services, risk assessment services, design & integration services, managed security services, and others.

Based on security type, the global market is segmented into application security, cloud security, endpoint security, network security, others security.

Based on application, the global market is segmented into pharmaceutical, medical devices, and biotechnology.

Key Players

The prominent players in the global healthcare IoT security market are Inside Secure SA, IBM Corporation, Cisco Systems Inc., Intel Corporation, Oracle Corporation, Sophos Group plc, Symantec Corporation, Trend Micro Inc, Checkpoint Software Technology, Kaspersky Labs, Fortinet Inc, Intelen Inc, Eurotech SpA, Deutsche telekom AG, SecureFLO LLC, Dell Corporation, Atmel Corporation, Security Mentor, Klynveld Peat Marwick Goerdeler, Agile Cyber Security Solutions, LLC.

Some of the key strategies followed by the players operating in the global healthcare IoT security market are innovation, product development, acquisition, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-iot-security-market-946

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Intracranial Pressure (ICP) Monitoring Market Trends And Drivers Analysis 2020 To 2024

Intracranial pressure (ICP) monitoring is used in treating patients suffering from severe brain injury. In this process a sensor device is been used and placed inside the head to measure the pressure inside the skull and send it to a recording device

Intracranial pressure monitoring can be performed in following three ways:

Intraventricular Catheter: is the most accurate method. In this method Intraventricular Catheter is inserted through a hole in the skull and place in the lateral ventricle.

Subdural Screw: In this method hollow screw is placed in the skull. It is placed between a membrane that protects the spinal cord and the brain.

Epidural Sensor: The Epidural Sensor is placed between the skull and dural tissue by drilling a hole in the skull

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/703

Intracranial pressure monitoring (ICP) market Application:

Intracranial pressure (ICP) monitoring is mainly used in hospitals for patients suffering from brain injury, meningitis and intracerebral hemorrhage. There are multiple ICP products that have been used in hospitals such as Surgical Instruments, IAP-Monitoring, Hydrocephalus, CSF drainage and many more.

The microtransducers and ventriculostomy is included invasive method whereas tympanic membrane displacement, transcranial Doppler, CT scan/ MRI, optic nerve sheath diameter, and fundoscopy is included in noninvasive methods

Intracranial pressure (ICP) monitoring market growth influencer:

The major growth drivers of Intracranial pressure monitoring market is increasing global incidence and prevalence of neurological disorders, rising awareness about neurodegenerative diseases, technological advancements in brain monitoring devices and growing incidence of traumatic brain injuries.

The shortage of trained professionals, high cost of complex brain monitoring devices, unfavorable reimbursement policies and concerns regarding the accuracy of diagnostic devices are the major restraints of ICP market.

Intracranial pressure (ICP) monitoring market segmentation:

ICP monitoring market segmentation can be done by method, market, Instrument, applications and End-users.

ICP monitoring market by Method: Invasive and Non- invasive

ICP monitoring market by Market: external ventricular drain, fiber optic monitor, strain gauge transducer and air-pouch device market.

ICP monitoring market by Instrument: Devices and accessories

ICP monitoring market by Applications: Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, and Subarachnoid Hemorrhage

ICP monitoring market by End-users: Trauma centers, hospitals, clinics and diagnostic laboratories.

Intracranial pressure (ICP) monitoring market major players:

Natus Medical Inc. (U.S.), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (U.K.), Siemens Healthcare (Germany), Compumedics Ltd. (Australia), Electrical Geodesics Incorporated (U.S.), Medtronic Inc. (Ireland), CAS Medical Systems, Inc. (U.S.) and Advanced Brain Monitoring (U.S.)

The reports also covers brief analysis of Geographical Region includes:

Americas: North America: US, Canada; Europe: Western Europe: Germany, France, Italy, Spain, U.K, Rest of Western Europe; Eastern Europe: Poland, Russia; Asia– Pacific: Asia: China, India, Japan, Rest of Asia; Pacific Countries: Australia, New Zealand; The Middle East& Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/intracranial-pressure-monitoring-market-703

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Hydrocephalus Market Pipeline Review, 2020- Identify Key Business Opportunities

The Global Hydrocephalus Market is growing at a healthy pace and is expected to be USD 1,348.00 million in 2017, at a CAGR of 4.4% during the forecast period 2018-2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1719

Hydrocephalus is a condition that characterized by buildup of cerebrospinal fluid (CSF) in the brain cavities (ventricles). The ventricles expand as a result of fluid accumulation, causing an abnormal increase in brain size. In normal conditions, the cerebrospinal fluid usually flows through the cavities of the brain and spinal column, but in hydrocephalus, the excessive CSF accumulation causes damage to the brain tissues, leading to a number of brain impairments. This condition can occur in any age, but it is more prevalent in infants and older adults. The increasing prevalence of hydrocephalus is directly responsible for the market growth. The major cause for this condition in children is found to be malnourishment of the fetus. this condition is mostly genetic however, it can also manifest in adults and is known as acquired hydrocephalus.

Shunting is a primary line of treatment for hydrocephalus. Shunting creates a bypass for the accumulated fluid to flow to other parts of the body. The increasing prevalence of traumatic brain injuries due to accidents and shifting patient preference towards minimally invasive surgeries in geriatric population are considered as the key factors that are projected to encourage the growth of the global hydrocephalus market in the coming years. In addition to this, the growing disposable income among consumers and the rapid development in the healthcare infrastructure are further predicted to enhance the growth of the overall market in the next few years.

Market Dynamics

The market for hydrocephalus is not very well developed due to lack of attention paid to the treatment of the disease. Following the development of shunts for draining the accumulated cerebrospinal fluid and scans to diagnose this condition, there have been improvements in terms of treatments to provide short-term relief to patients. However, there are efforts to develop treatments to address the disease at initial stages and this has ensured a positive growth trend for the market.

Further, Posttraumatic hydrocephalus (PTH) is a recurrent and serious complication that follows a traumatic brain injury (TBI). The prevalence of this condition varies greatly based on different criteria for its diagnosis. It can be caused by the blockage of normal cerebrospinal fluid (CSF) flow, overproduction of CSF, or insufficient absorption that result in excessive accumulation of CSF around the brain

The use of ICP devices is for measuring the fluid pressure within the brain which may be caused by trauma or other conditions. ICP monitoring has a significant importance in diagnostic and post-operative procedures with cranial injury as seen in cases of stroke, hydrocephalus, and trauma. According to the estimate of the Centers for Disease Control and Prevention (CDC) in 2017, more than 1.75 million traumatic brain injuries occur in North America, annually and these monitoring devices enable surgeons to save lives of patients with timely intervention and treatment. The increasing accidental cases causing traumatic brain injuries are going to act as drivers for the hydrocephalus market.

Segmentation

The global Hydrocephalus market is segmented on the basis of type, diagnostic, treatment, end user. On the basis the type, the market is segmented into congenital hydrocephalus, acquired hydrocephalus, normal-pressure hydrocephalus, ex-vacuo hydrocephalus. on the basis of the diagnostic, the market is segmented into CT scan – head, MRI, head ultrasound. on the basis of treatment, it is segmented into surgery – shunt insertion, ventriculostomy, medication. on the basis of end user, it is segmented into hospitals & clinics, diagnostic centres, academic institutions and research organizations

Regional Analysis

The global market for hydrocephalus is segmented on the basis of regions into Americas, Europe, Asia Pacific, and Middle East & Africa.

The Americas held the largest share of the global hydrocephalus market owing to the rising prevalence of hydrocephalus, the presence of a well-developed healthcare sector, and the major market players. The continuous increase in the number of Americans affected from hydrocephalus coupled with ongoing research in neuroscience aid to the market growth. On a regional basis, the Americas is divided into North America and South America. North America is estimated to lead due to the presence of developed economies such as the US and Canada within the region. South America, however, is estimated to have the faster growth.

Europe stands second in the global market due to the constant evaluation of various techniques by neurosurgeons for the improvement of hydrocephalus management, is expected to drive growth in this market. Moreover, shunt manufacturers are engaged in investment for development of novel and improved shunts in order to tackle the pitfalls associated with the existing designs. The child population, aging in between 0 and 14 years, is estimated to increase from 17.6% of the total population in 2013 to 18.4% of the total population by 2020. This provides favorable background for market growth in Europe.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hydrocephalus-market-1719

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Clinical Laboratory Test Market In Depth Study And Analysis Published, 2022

The Global Clinical Laboratory Test Market is expected to register 6.5% CAGR to reach USD 324508.8 Million by 2022.

Clinical laboratory testing has emerged as a rapidly growing segment in healthcare over the past few years. Clinical laboratory testing includes all routine check-ups and other pathology tests for the diagnosis of various diseases ranging from CBC and other routine blood tests to anatomical, pathological testing, molecular, immunological, drug testing, and other tests for disease diagnosis and treatment.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1649

CBC and other routine blood tests are the most common type of tests that are used for screening certain disorders leading to an increase or decrease of cell counts. These tests help to diagnose a broad range of conditions from anemia and infections to cancer. Increasing prevalence of diseases and growing awareness and concerns regarding health issues all around the globe are the primary reasons for the growth of these routine check-ups and overall clinical laboratory testing market. On the other hand, the major factor restricting the growth of market is the strict government rules and regulations regarding laboratory testing. The global market has significant growth opportunities due to the various untapped therapeutic testing markets.

Market Dynamics

The global clinical laboratories market is segmented by routine medical testing includes full-body testing includes eye check-up, blood test, diabetes testing, and others; anatomical pathology testing includes histological analysis and urinalysis; esoteric medical testing includes tests for infrequent diseases; diagnostic imaging testing includes radiation procedures such as X-ray, CT, MRI, and ultrasound used for diagnosing the patient’s condition through imaging of internal organs.

Currently, around 617 million people, which is approximately 8.5% of people worldwide are aged 65 and over. According to the report “An Aging World: 2015,”, this percentage is expected to jump to nearly 17% by 2050 (1.6 billion). This is the primary reason for the swift growth of clinical laboratories. Besides these, other factors responsible for driving the clinical laboratory market are physician contribution to improve laboratory testing by counseling the patient for a screening of uncertain diseases or symptoms.

Segmentation

The global clinical laboratory tests market is segmented into types of laboratories, types of test, and region. Based on types of laboratories, the global clinical laboratory tests market is segmented into hospital-based laboratories, central/independent laboratories, physician office-based laboratories, and others. Based on types of test, the global market is segmented into complete blood count (CBC), basic metabolic panel (BMP), HbA1c tests, HGB/HCT tests, comprehensive metabolic panel tests, BUN creatinine tests, renal panel tests, electrolytes testing, liver panel tests, and lipid panel tests. Based on application, the global market is segmented into parasitology, virology, hematology, toxicology, immunology/serology, histopathology, and urinalysis. Based on end user, the global market is segmented into hospital-based laboratories, stand-alone laboratories, and clinics-based laboratories.

Regional Analysis

The clinical laboratory market is witnessing significant growth in developing and developed countries such as the UK, the US, China, India, and Spain.

The global clinical laboratory test market, based on region, is segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. There is a widespread presence of diseases related to hypertension, cardiovascular diseases, cancer, stroke, and other fatal diseases, due to which the expenditure on healthcare and R&D is the highest in North America, followed by Europe. The use of clinical laboratories by research institutes, hospitals, and clinics have increased the demand for clinical laboratories across the world. Asia-Pacific is the fastest-growing market in clinical laboratory tests due to the large geriatric population in China and Japan.

Key Players

The prominent players in the global clinical laboratory test market are AURORA Diagnostics, Laboratory Corporation of America, LifeLabs Medical Laboratories, Quest Diagnostics, and Sonic Healthcare.

The players operating in the global clinical laboratory test market are focusing on product launches and expanding their global footprints by entering untapped markets.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/clinical-laboratory-test-market-1649

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com